Etiqueta: ms

In yet another merger of Big Pharma and academia, two of the world’s leading research entities join forces for combined stem cell R&D.

Three patients with multiple sclerosis show significant improvement after being treated with their own fat-derived adult stem cells.

Researchers unravel the cellular mechanisms of myelin formation from human embryonic stem cells.

Scientists demonstrate both safety and feasibility of an adult stem cell therapy for the treatment of spinal cord injuries.

Opexa Therapeutics shows strong preclinical data for its autologous adult stem cell diabetes therapy.

Mothers of toddlers in England are being encouraged to store the baby teeth of their children as a future source of stem cells.

Dr. Bernardine Healy has written an article in U.S. News and World Report entitled Why Embryonic Stem Cells Are Obsolete.

Researchers at Northwestern University have once again achieved encouraging results in the treatment of multiple sclerosis with adult stem cells.

Doctors in Chicago use adult stem cells derived from bone marrow to halt and reverse the progression of multiple sclerosis.

Opexa Therapeutics holds an informative briefing on both executive and scientific company news.